This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harroch, S.
Right arrow Articles by Schlessinger, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harroch, S.
Right arrow Articles by Schlessinger, J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 2000, p. 7706-7715, Vol. 20, No. 20
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

No Obvious Abnormality in Mice Deficient in Receptor Protein Tyrosine Phosphatase beta

S. Harroch,1 M. Palmeri,1 J. Rosenbluth,2 A. Custer,3 M. Okigaki,1 P. Shrager,3 M. Blum,4 J. D. Buxbaum,5 and J. Schlessinger1,*

Department of Pharmacology and the Skirball Institute1 and Department of Physiology and Neuroscience,2 New York University Medical Center, New York, New York 10016; Department of Neurobiology and Anatomy, University of Rochester Medical Center, Rochester, New York 146423; and Departments of Neurobiology4 and Psychiatry,5 Mount Sinai School of Medicine, New York, New York 10029

Received 27 April 2000/Returned for modification 30 June 2000/Accepted 12 July 2000


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The development of neurons and glia is governed by a multitude of extracellular signals that control protein tyrosine phosphorylation, a process regulated by the action of protein tyrosine kinases and protein tyrosine phosphatases (PTPs). Receptor PTPbeta (RPTPbeta ; also known as PTPzeta ) is expressed predominantly in the nervous system and exhibits structural features common to cell adhesion proteins, suggesting that this phosphatase participates in cell-cell communication. It has been proposed that the three isoforms of RPTPbeta play a role in regulation of neuronal migration, neurite outgrowth, and gliogenesis. To investigate the biological functions of this PTP, we have generated mice deficient in RPTPbeta . RPTPbeta -deficient mice are viable, are fertile, and showed no gross anatomical alterations in the nervous system or other organs. In contrast to results of in vitro experiments, our study demonstrates that RPTPbeta is not essential for neurite outgrowth and node formation in mice. The ultrastructure of nerves of the central nervous system in RPTPbeta -deficient mice suggests a fragility of myelin. However, conduction velocity was not altered in RPTPbeta -deficient mice. The normal development of neurons and glia in RPTPbeta -deficient mice demonstrates that RPTPbeta function is not necessary for these processes in vivo or that loss of RPTPbeta can be compensated for by other PTPs expressed in the nervous system.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Protein tyrosine phosphatases (PTPs), in concert with protein tyrosine kinases (PTKs), regulate signal transduction pathways by tyrosine phosphorylation and dephosphorylation. PTPs comprise a structurally diverse family of enzymes. One group of PTPs exhibit structural features that are also common to cell surface receptors and cell adhesion molecules (CAMs), suggesting that these receptors may play a role in cell-cell communication (4, 43). These receptor-like PTPs (RPTPs) are composed of an extracellular domain, a single transmembrane domain, and a cytoplasmic portion that contains one or two tyrosine phosphatase domains. RPTPbeta (also known as PTPzeta ) and RPTPgamma are two members of a subfamily of RPTPs that contain a region in their extracellular domains that has sequence homology to the enzyme carbonic anhydrase (CAH) (2, 3, 24, 25). In both RPTPbeta and RPTPgamma , the CAH domain is followed by a fibronectin domain type III repeat and by a long unique sequence termed the spacer domain. Three different isoforms of RPTPbeta are expressed as a result of alternative mRNA splicing: a short and a long form that differ by the presence of a stretch of 860 amino acid residues in the spacer domain and a secreted form composed of only the extracellular domain of RPTPbeta , also known as 3F8 proteoglycan or phosphacan. Both transmembrane RPTPbeta s and the phosphacan isoform are predominantly expressed as chondroitin sulfate proteoglycans.

Previous studies have suggested a role for RPTPbeta in gliogenesis and neuron-glial cell interaction, neurite outgrowth, and neuronal migration, as well as in regeneration after injury (21, 26, 43).

RPTPbeta is expressed predominantly by glial cells, astroglia, oligodendrocytes, and Schwann cells but also by neurons throughout the developing and adult nervous system (5, 41). Both transmembrane forms of RPTPbeta are predominantly expressed in glial progenitors cells located in the ventricular and subventricular zone, where active cell proliferation occurs. Phosphacan is expressed at high levels by more mature glial cells, which suggests that the expression of RPTPbeta is regulated during glial cell differentiation (6). Furthermore, RPTPbeta expressed at the surface of glial cells binds to a cell recognition complex on neurons consisting of several proteins which include contactin, Caspr (also named paranodin) (34, 35), and Nr-CAM (40). On the basis of the localization of Caspr at the paranode, it was suggested that RPTPbeta is involved in myelination and formation of the node (10).

RPTPbeta has been shown to bind to a variety of CAMs and matrix components such as tenascin (18), Nr-CAM (40), L1, contactin (34), and pleiotrophin (28). Overlapping localization of phosphacan and most of the binding proteins is observed in the central nervous system (CNS), suggesting that these interactions could occur in vivo and may be involved in the control of cell proliferation, migration, adhesion, neurite outgrowth, and pathfinding in the brain. It was shown that chondroitin sulfate proteoglycans and CAM are often upregulated during brain damage or nerve injury (12, 30). Furthermore, it was demonstrated that RPTPbeta is upregulated after sciatic nerve crushes, suggesting a role of RPTPbeta in regeneration after injury (26).

The three isoforms of RPTPbeta are expressed throughout the developing and adult nervous system. Interestingly, phosphacan binds to neurons and inhibits adhesion and neurite outgrowth (13, 17). In contrast, the extracellular portion of RPTPbeta has been shown to induce neurite outgrowth. RPTPbeta induces neurite outgrowth through its interaction with contactin and Nr-CAM (40). In addition, phosphacan can also stimulate neurite outgrowth of mesencephalic and hippocampal neurons (11). It was demonstrated that heterophilic interaction between RPTPbeta and pleiotrophin mediates cell migration of cortical neurons, a process blocked by the PTP inhibitor sodium vanadate (28). Moreover, it has been shown that mesencephalic dopaminergic (DA) neurons express phosphacan. A heterophilic interaction between phosphacan on the neurons and L1 on the fibers may be involved in the control of migration of mesencephalic DA neurons (33), suggesting that RPTPbeta may play a more general role in cell migration.

To explore the biological function of RPTPbeta in vivo, we have generated mice deficient in the three isoforms of RPTPbeta . These RPTPbeta -/- mice are viable and fertile and showed no gross anatomical alterations. We have tested the importance of RPTPbeta in myelination, neurite outgrowth, and node formation in the adult mouse. Our results demonstrate that RPTPbeta is not required for neurite outgrowth and paranode formation, in contrast to what has been proposed based on in vitro experiments. However, ultrastructure of the CNS nerves suggests a fragility of the myelin but with no alteration of conduction velocity.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

RPTPbeta targeting vector. A genomic clone containing one part of the CAH domain of the RPTPbeta gene was isolated from a lambda FIXII mouse genomic library (129SV/Ev strain; Stratagene) by hybridization with a rat cDNA fragment corresponding to the CAH domain. A targeting vector was designed to contain 4.1 kb of 5' homologous sequence, a pgk-neo cassette (42) replacing one exon in the opposite direction to RPTPbeta gene transcription, 2.1 kb of 3' homologous sequence, and the herpes simplex virus (HSV) thymidine kinase gene (tk). Embryonic stem (ES) cells were grown on mitomycin C-treated primary embryonic fibroblasts that had been extracted from day 15 embryos at 37°C in Dulbecco's modified Eagle's medium supplemented with 15% heat-inactivated fetal bovine serum (HyClone), 0.1 mM 2 mercaptoethanol, 1 mM sodium pyruvate, and 103 U of leukemia inhibitory factor (GIBCO) per ml. Cells (7 × 106) were electroporated in 800 µl of phosphate-buffered saline (PBS) with 32 µg of NotI-linearized targeting vector DNA at 240 V and 500 mF using a gene pulser (Bio-Rad) and plated on gelatin-coated plastic dishes. After 48 h, the cells were transferred to growth medium supplemented with G418 (150 µg/ml; GIBCO) and ganciclovir (2 µg/ml; Syntex). ES cell clones were screened by PCR using the enzyme Expand (Boehringer) and oligonucleotides located in the neo gene and in RPTPbeta gene. Positive clones were then confirmed by Southern blot analysis. To accomplish this, genomic DNA was digested with EcoRI, transferred onto nylon filters, and hybridized with a radioactively labeled PstI fragment from the original phage clone (Fig. 1). Three independent targeted ES clones were used in embryo aggregation experiments for generation of mice. Chimeric mice were crossed to Swiss Webster mice. Heterozygous and homozygous animals were identified by PCR and Southern blot analysis.


View larger version (18K):
[in this window]
[in a new window]
 
FIG. 1.   RPTPbeta gene organization and structure of the disrupted RPTPbeta gene. (A) Restriction map of the mouse RPTPbeta gene. Translated exons are represented by closed boxes and numbered I to III. E, B, H, P, RV, S, and X represent cleavage sites for EcoRI, BamHI, HindIII, PstI, EcoRV, SacI, and XbaI (not all sites given), respectively. WT, wild type. (B) Restriction map of the RPTPbeta -targeting construct p5'PGKneo3'TK, containing 4 and 2.1 kb of homologous sequences on the 5' and 3' sites of the neo insertion, respectively. pgk-neo and HSV tk cassettes are indicated by boxes. Arrows indicate transcriptional orientation of the genes. N represents cleavage site for NotI. (C) Structure of the RPTPbeta gene after homologous recombination and localization of probes. Horizontal bars indicate the localization of 5' and 3' hybridization probes. Small arrows represent the position of the oligonucleotide used for PCR analysis.

RNA preparation and Northern blot analysis. Total RNAs from brains of RPTPbeta +/+, RPTPbeta +/-, and RPTPbeta -/- mice were isolated by the guanidine thiocyanate method (7). RNA were electrophoresed in a 1% agarose gel containing 7% formaldehyde and transferred to a nylon membrane (Schleicher & Schuell). Hybridization was performed with a radiolabeled 500-bp mouse cDNA probe coding for the CAH domain in 0.25 M sodium phosphate buffer (pH 7.4)-7% sodium dodecyl sulfate, followed by autoradiography.

Primary antibodies. Rabbit polyclonal antibody against CasprI was a gift from E. Peles and used at a dilution of 1:5,000; rabbit polyclonal antibody against ankyrinG, a gift from S. Lux, was used at a dilution of 1:500. Mouse monoclonal antibody against the sodium channel (previously characterized by Rasband et al. [37]) was used at a dilution of 1:10,000. Rabbit anti-rat tyrosine hydroxylase (TH) polyclonal antibody (Pel-Freeze) was used at 1:1,000.

TH staining. Mice were anesthetized and transcardially perfused with ice-cold saline followed by perfusion with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer, pH 7.4 (PB). The brains were removed, cut into 3- to 4-mm blocks containing the midbrain, and postfixed in 4% PFA for 5 h. Subsequently, the brain blocks were placed in cold 30% sucrose in 0.1 M PB overnight, and 40-µm vibratome sections were cut. Using a random start, a 1:8 series of sections was collected for TH immunocytochemistry. Free-floating sections were incubated overnight at 4°C with a rabbit anti rat-TH polyclonal antibody (Pel-Freeze) (1:1,000 in PBS-3% goat serum-0.3% Triton X-100). After removal of the primary antibody and a wash with PBS, the sections were incubated for 2 h at room temperature with anti-rabbit immunoglobulin G conjugated with biotin (Amersham) (1:200 in PBS-3% goat serum-0.3% Triton X-100). The secondary antibody was removed, sections were washed, the reaction was quenched for 5 min in 0.3% H2O2 in PBS, and the samples were incubated with ExtraAvidin-peroxidase (1:200; Sigma) for 1 h before being incubated with 3,3'-diaminobenzidine.

Light microscopy. Mice were deeply anesthetized and perfused through the left ventricle with 3% PFA in 0.1 M PB. Brains were removed and postfixed in the same fixative overnight, washed in PB, and embedded in paraffin. Sections of 6 µm were cut and stained with cresyl violet. For Timm staining, mice were perfused through the left ventricle with sodium sulfide solution (19) followed by 4% PFA. Then 6-µm paraffin sections were mounted and stained in darkness at 24°C as described elsewhere (19). After staining for 15 or 45 min, the sections were counterstained with cresyl, dehydrated, and coverslipped.

Electron microscopy. Mice were anesthetized with pentobarbital and perfused transcardially with a fixative consisting of 3% glutaraldehyde and 2% PFA in 0.1 M cacodylate buffer (pH 7.3). Optic nerve and spinal cord segments were dissected out, rinsed, postfixed in 1 to 2% osmium tetroxide, with or without added 1.5% potassium ferricyanide, in 0.1 M cacodylate buffer, dehydrated in a graded series of alcohols, and embedded in Araldite or an Epon-Araldite mixture. Sections of 1 µm were cut with glass knives and stained with 1% toluidine blue for survey by light microscopy. Selected areas were then sectioned at ~0.1 µm, mounted on copper grids, stained with potassium permanganate followed by ethanolic uranyl acetate, and examined in a Philips 300 electron microscope. Both cross and longitudinal sections were studied. Animals studied ranged in age from 2 to 9.5 months.

Suction electrode recording. Mouse optic nerves were dissected and placed in a recording chamber that was continuously perfused and temperature regulated. The standard Locke's solution contained NaCl (154 mM), KCl (5.6 mM), CaCl2 (2 mM), D-glucose (5.6 mM), and HEPES (10 mM, pH 7.4). For stimulation and recording of compound action potentials (CAPs), each end of the nerve was drawn into a suction electrode. Stimuli consisted of 50-µs pulses that were adjusted to 10% above the level required for a maximal response. After a stimulus, CAPs were amplified, digitized, recorded, and analyzed with a laboratory computer. Conduction velocity was calculated as the length of the nerve divided by the time to the first peak amplitude of the CAP. For some experiments, CAPs were measured, and then nerves were fixed and used for labeling experiments.

Immunocytochemistry. Optic nerves were dissected, fixed in 4% PFA (pH 7.2) for 30 min, and soaked overnight in 20% sucrose at 4°C. The nerves were then frozen in OCT mounting medium (Miller), cut into 10-µm sections on a microtome, and dried on gelatin-coated coverslips. The sections were incubated in PBTGS (45 ml of 0.1 M PB, 150 µl of Triton X-100, 5 ml of goat serum) for 1 to 2 h to permeabilize and block. All subsequent solutions used PBTGS for dilutions or washing, and all incubations were done at room temperature. Three washes of 5 min were done after each antibody incubation. Rabbit polyclonal antibodies were applied first for 15 h. Anti-rabbit Alexa 488 (1:500; Molecular Probes, Eugene, Oreg.) was then added for 1 h. For double labeling, mouse monoclonal antibodies were added for 15 h, and anti-mouse Cy3 (1:500; Accurate Chemicals, Westbury, N.Y.) was applied for 1 h. Sections were then washed serially in PBTGS, 0.1 M PB, and 0.05 M PB and allowed to air dry. The labeled sections were mounted on slides and viewed under a Nikon Microphot-SA fluorescence microscope. Images were taken by a C4742-95 cooled charge-coupled device camera (Hamamatsu) controlled by Image Pro software (Media Cybernetics).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Generation of RPTPbeta -deficient mice. Using a rat cDNA fragment corresponding to the CAH domain of the RPTPbeta gene, a clone including a 3' part of this domain was isolated from a mouse 129Sv/Ev genomic library. The targeting vector for the RPTPbeta gene comprised 4.1 kb of 5' homologous sequence, a pgk-neo cassette in opposite direction to RPTPbeta gene transcription (42) replacing one exon, 2.1 kb of 3' homologous sequence, and HSV tk for selection against random integration (29). Homologous recombination with this targeting vector results in a loss of exon 2 and in inadequate splicing, resulting in a null mutation.

After electroporation of the linearized targeting vector into either R1 or W4 ES cells followed by double selection with G418 and ganciclovir, approximately 1 clone out of 100 or 1 clone out of 50, respectively, carried the desired mutation as determined by PCR (data not shown) and verified by Southern blot analysis with the 3' external probe. The presence of a new EcoRI site introduced by insertion of neo sequence into RPTPbeta gene was detected by the appearance of a 4.5-kb band in addition to the wild-type band of 10 kb.

Chimeric mice were obtained after aggregation of targeted ES cells. Chimeric males showed germ line transmission of the disrupted RPTPbeta gene as analyzed by Southern blot analysis. Crossing of heterozygous RPTPbeta -/+ offspring yielded homozygous RPTPbeta -deficient mice with strictly Mendelian frequencies. Southern blot analysis of these mice with 3' and 5' external probes (Fig. 2A), as well as with a neo probe, showed the pattern expected for a single integration by homologous recombination (data not shown). We subsequently used PCR with a reverse oligonucleotide in the neo promoter and a forward oligonucleotide on the 3' arm or in exon II to screen for homozygous animals (Fig. 1 and 2B).


View larger version (35K):
[in this window]
[in a new window]
 
FIG. 2.   Southern, PCR, Northern, and immunoblot analyses of wild-type and RPTPbeta -deficient mice. (A) Southern blot analysis. DNA from wild-type, RPTPbeta -/+, and RPTPbeta -/- mice digested with EcoRI was hybridized with a 3' probe (PstI probe). The 10-kb band represents the wild-type allele, and the 4.5-kb band represents the mutant allele. (B) PCR analyses. For easy screening, we used a PCR wherein the wild-type (WT) allele is amplified as a 500-bp DNA and the mutant allele is amplified as a 300-bp product. (C) Northern blot analysis. RNA from brains of RPTPbeta +/+, RPTPbeta -/-, and RPTPbeta -/+ mice was hybridized with a 500-bp cDNA fragment encoding the mouse CAH domain. Arrows point to the three transcripts of RPTPbeta in both wild-type and heterozygous RNAs that are absent in RPTPbeta -/- mice. Sizes are indicated in kilobases.

To determine whether the mutated RPTPbeta gene is transcribed, total RNAs from brains of RPTPbeta -/-, RPTPbeta -/+, RPTPbeta +/+ mice were subjected to Northern blot analysis. After hybridization with a mouse cDNA specific probe for the CAH domain, no hybridization was detectable with RNA from RPTPbeta -deficient mice, while RPTPbeta mRNAs of 9.5, 8.5, and 6.4 kb were clearly detected in RPTPbeta -/+ and RPTPbeta +/+ mice, indicating that the mutated gene is not transcribed. All forms of mRNA having been lost, we therefore concluded that insertion of the mutation into the RPTPbeta gene generated mice lacking the soluble form phosphacan as well as the two transmembrane forms. RPTPbeta -/+ animals showed similar amounts of RPTPbeta mRNAs and were therefore used as controls.

Morphological analysis of the CNS of RPTPbeta -deficient mice. At the light microscopic level, the general morphology of brains of 2-month-old RPTPbeta -/- mice appeared normal and indistinguishable from that of wild-type littermates. Cross sections through the hippocampi of RPTPbeta -deficient mice displayed a normal pattern of migration of pyramidal cells in the dentate gyrus (Fig. 3A and B). In addition, we found no abnormalities in the subventricular zones of RPTPbeta -/- mice (data not shown). In the cerebella of 2-month-old RPTPbeta -deficient mice, the molecular layer, Purkinje cell layer, and internal granular cell layer appeared normal (Fig. 3C and D). Because RPTPbeta is also expressed in cortical neurons (41), we also compared the lamination and organization of the cortex. We chose to look at the somatosensory cortex, where the layers are most distinguishable. The number of cells and organization in the six layers were apparently similar in wild-type and RPTPbeta -deficient mice (Fig. 3E and F), indicating that RPTPbeta is not necessary for cortical neuron migration. To further investigate the cortex, we examined the distribution of specific neuronal markers. Phosphacan is expressed by interneurons in the cortex (20). The calcium-binding protein parvalbumin and calbindin are expressed in distinct subpopulations of neurons. We investigated the density of inhibitory interneurons by immunocytochemistry using antibodies to the Ca2+-binding protein parvalbumin as a marker for a subpopulation of GABAergic (gamma amino butyric acid) neurons. The density of parvalbumin-immunoreactive cells did not differ between wild-type and mutant animals in this region (data not shown). Immunostaining with anticalbindin (data not shown) revealed no difference in number, localization, or expression pattern between RPTPbeta -/- and control cortex samples.


View larger version (152K):
[in this window]
[in a new window]
 
FIG. 3.   Analysis of the hippocampi, cortices, and cerebella of RPTPbeta -deficient mice by light microscopy. Sections of 6 µm through hippocampi (A and B), cerebella (C and D), and cortices (E and F) of adult wild-type (A, C, and E) and RPTPbeta -deficient (B, D, and F) mice were stained with Nissl stain. The overall histology, number, and localization of each cell type in these regions of the brain appear normal in RPTPbeta -deficient mice. ml, molecular layer; pl, Purkinge cell layer; gl, internal granular layer; DG, dentate gyrus.

Various experiments in vitro have suggested a role of RPTPbeta in neurite outgrowth. For example, RPTPbeta promotes neurite outgrowth from mesencephalic and hippocampal neurons (8, 11). To test this hypothesis, we inspected the dentate gyrus of the hippocampus, where RPTPbeta is highly expressed, in relation to axonal projections, the mossy fibers (MFs). MFs are the axon of the neuron, which form the granule cell layer of the dentate gyrus. MF axons of the dentate granule cells establish synaptic contacts with neurons in the dentate hilus and with pyramidal cells of the hippocampal CA3 (1). We used Timm's staining, which specifically reveals MFs and their synaptic expansion, to study MFs in RPTPbeta -/- and control mice. Timm's stain of wild-type and RPTPbeta -/- hippocampus sections did not reveal reduced staining or an alteration of the distribution of the fibers in RPTPbeta -/- mice (data not shown).

Normal migration of mesencephalic neurons in RPTPbeta -/- mice. Mesencephalic DA neurons, generated in the ventricular zone of the mesencephalon, migrate first ventrally from the ventricular surface along radial glial processes and then laterally along tangentially arranged nerve fibers to their destinations, the substantia nigra pars compacta, the reticular formation, and the ventral tegmental area. The expression of phosphacan by DA neurons and its interaction with L1 and Ng-CAM have implicated a role for it in the lateral migration of DA neurons (33). This study showed that the laterally migrating substantia nigra DA neurons express phosphacan. Since the ventral tegmental DA neurons seem to migrate only radially, they may not require phosphacan for proper migration. Thus, in the absence of phosphacan, we may observe all DA neurons clustered in the ventral tegmental area, with an absence of DA neurons in the substantia nigra. Migration of DA neurons was histologically examined in RPTPbeta -deficient mice and control animals by a series of sections through the midbrain stained with an antibody directed against TH, a DA-synthesizing enzyme. As seen in Fig. 4, DA neurons migrate properly in RPTPbeta -deficient mice.


View larger version (65K):
[in this window]
[in a new window]
 
FIG. 4.   Localization of mesencephalic DA neurons. Coronal sections of RPTPbeta -/- and RPTPbeta -/+ adult animals were stained with anti-TH antibodies, revealing mesencephalic DA neurons. Wild-type and RPTPbeta -/- DA neurons migrated properly laterally and did not localize ventrally. SN, substantia nigra.

Electron microscopy of optic nerves of RPTPbeta -deficient mice. RPTPbeta is expressed by cells of the oligodendrocyte lineage during development and in the adult (6). It has been suggested that RPTPbeta is involved in formation of the node of Ranvier (10). We evaluated myelination in 2-month-old brains stained with luxol fast blue, a stain specific for myelin, and detected no difference in staining between wild-type and RPTPbeta -/- mice (data not shown).

We then analyzed the ultrastructure of myelin in the optic nerves of animals at various ages. Myelin in the optic nerves and spinal cords of both old and adult RPTPbeta -/- mice is grossly normal in appearance (Fig. 5A and B) with respect to periodicity and thickness. As in the wild-type animals, myelin thickness in the RPTPbeta -/- animals increases with fiber diameter. The radial component is present, and the inner and outer mesaxons form tight junctions (Fig. 5D). In comparison with wild-type controls, however, there is a greater tendency for fragmentation of the RPTPbeta -/- myelin (i.e., separation and disintegration of lamellae), especially in thicker sheaths (Fig. 5C), and for deformation of the myelin sheath profiles, resulting in redundant folds (Fig. 5C) (38). In addition, in the myelin sheaths of RPTPbeta -/- animals, cytoplasm-containing lamellae can be found extending into juxtaparanodal regions (Fig. 6D) as well as in internodal myelin (Fig. 5C).


View larger version (200K):
[in this window]
[in a new window]
 
FIG. 5.   Ultrastructure of the optic nerve. (A) Survey view of wild-type optic nerve cross section (magnification, ×12,600). The myelin sheaths surrounding the larger axons appears more compact than those in panel B. (B) Survey view of RPTPbeta -/- optic nerve cross section (×12,600). In the larger fibers, myelin lamellae tend to separate. Extraneous whorls (arrow) of myelin are apposed to an oligodendrocyte. (C) Large fiber from RPTPbeta -/- optic nerve (×31,500). The sheath appears somewhat raveled (black arrows) and in one region the lamellae contain cytoplasm (white arrow). Just above, two (large 1 and 2) fibers are surrounded by sheaths that form redundant folds (small numbers). (D) Small fiber from RPTPbeta -/- optic nerve (×182,000). Both inner and outer mesaxons form tight junctions. Radial component (arrows) is visible in one quadrant of the sheath.

Nodal and paranodal areas in the RPTPbeta -/- animals also appear grossly normal. The nodal gap approximates 1 µm, and the nodal axolemma displays a typical undercoating (Fig. 6B). Paranodal loops form junctions with the axolemma. The junctional cleft is ~2 nm wide and contains transverse bands, the periodic dense ridges that extend between the membranes of the paranodal axolemma and the glial loops (Fig. 6C). In small fibers, the overlapping pattern of the terminal loops displays the normal arrangement, i.e., with the outermost loops closest to the node and ending against the axolemma (Fig. 6B). In more heavily myelinated fibers of both wild-type (Fig. 6A) and RPTPbeta -/- (Fig. 6C) animals, some of the terminal loops end either on other loops or in an everted pattern facing away from the axolemma.


View larger version (151K):
[in this window]
[in a new window]
 
FIG. 6.   Analysis of the node and paranode by electron microscopy. (A) Paranodal junction from a wild-type spinal cord (magnification, ×100,000). Some terminal loops adjoin the axolemma and form junctions containing transverse bands (arrowheads); others do not reach the axolemma. The node of Ranvier (n) is at the right. The axon (ax), paranode (pn), and myelin sheath (m) are indicated. (B) Small fiber from RPTPbeta -/- optic nerve (×79,000). The node of Ranvier (right) shows undercoated plasma membrane (arrow). Myelin lamellae form a regular succession of overlapping terminal loops. (C) Detail of paranodal junction from a large fiber in RPTPbeta -/- spinal cord (×152,000). Some terminal loops end against the axolemma, forming junctions containing periodic transverse bands. Not all terminal loops reach the axolemma, however. (D) Paranodal (pn) and juxtaparanodal (in) regions of axon in a large fiber from RPTPbeta -/- spinal cord (×87,500). Cytoplasm-containing lamellae extend beyond the paranode toward the internode (arrows).

Na2+ channel clustering, Caspr localization, and conduction velocity of the optic nerve. Recent studies suggested that RPTPbeta might mediate interactions between axons and glial cells (35) through interaction with the contactin-Caspr complex. Caspr is a membrane protein highly expressed in the CNS that copurified with contactin when the CAH of RPTPbeta was used as an affinity probe. It was shown that Caspr is an essential component of the paranode (10). Thus, RPTPbeta could play a role in formation of the paranode and node of Ranvier. We therefore analyzed optic nerve sections, labeled for voltage-gated sodium channels to mark nodes of Ranvier and labeled for CasprI to mark paranodes (Fig. 7A). Both the nodes of Ranvier and paranodes in RPTPbeta -/- mice exhibited normal morphology and showed similar fluorescence staining with antibody markers compared with control animals (Fig. 7A). Optic nerve sections were also labeled for ankyrinG, a protein that links sodium channels to the cytoskeleton and is also located in the nodes of Ranvier (23). No differences in morphology or fluorescence intensity were seen with this label either. No difference was apparent in the number of labeled sites between RPTPbeta -/- and control animals with any of the antibodies used (Fig. 7A).



View larger version (44K):
[in this window]
[in a new window]
 
FIG. 7.   Localization of Na2+ channels and Caspr in the optic nerve and conduction velocity measurements. Normal nodes and paranodes are found in optic nerves of RPTPbeta -/- mice. (A) Optic nerve sections were labeled with antibodies specific for sodium channels (red), Caspr (green), and ankyrinG. No apparent differences in labeling were seen between nerves from wild-type and RPTPbeta -/- mice (scale bars = 10 µm). (B) Conduction velocity measurements of nerves from wild-type and RPTPbeta -/- mice at 25°C (P = 0.85) or 37°C (P = 0.38). Results represent mean ± standard deviation of four nerves.

Despite the normal clustering of Na2+ channels and Caspr localization in the optic nerves of RPTPbeta -deficient mice, functional changes could result from the alteration in myelin structure that have been detected in the optic nerves of RPTPbeta -deficient mice. To investigate the electrophysiological properties of CNS axons in RPTPbeta -deficient mice, the CAPs of RPTPbeta -/- optic nerves was recorded using suction electrodes, and conduction velocity was calculated using the fastest component of the CAP. Measurement of the conduction velocity at 25°C revealed no significant difference between RPTPbeta -/- and normal nerves (Fig. 7B). While the conduction velocity of RPTPbeta -/- nerves appeared to be somewhat slower than for controls at 37°C, this difference is not statistically significant (P = 0.377). The shape of CAPs in RPTPbeta -/- nerves was similar to that seen in control nerves.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The mutation introduced in the RPTPbeta gene abolishes expression of the three isoforms of RPTPbeta , the two transmembrane isoforms and the soluble isoform (phosphacan), since we have abolished transcription of the RPTPbeta gene. Nevertheless, the RPTPbeta -deficient mice described in this study are normal in their gross general behavior and with respect to fertility, body weight, and life span.

The gross anatomy of the brain and spinal cord and the morphology of the cerebellum of RPTPbeta -deficient mice do not show any alteration at the light microscopy level compared to their littermate controls. We could not detect aberrant localization of cells that normally express RPTPbeta in the cerebellum, hippocampus, or cerebral cortex. Therefore, RPTPbeta appears not to be necessary for the migration of these neural cell types to their correct locations in these areas of the CNS.

RPTPbeta and RPTPgamma belong to the same subfamily of RPTPs. Surprised by the lack of obvious phenotype in RPTPbeta -deficient mice, we tested whether the expression of RPTPgamma is altered in RPTPbeta -deficient mice to compensate for RPTPbeta deficiency. The expression of RPTPbeta is restricted to the nervous system, while RPTPgamma is ubiquitously expressed. However, certain neurons, especially cortical and hippocampal neurons, express both RPTPbeta and RPTPgamma . Northern blot analysis of mRNA prepared from adult RPTPbeta -/-, RPTPbeta -/+, or RPTPbeta +/+ brain mRNA showed no alteration of transcription of the RPTPgamma gene, indicating that RPTPgamma is not altered in RPTPbeta -/- mice (data not shown). However, we cannot rule out the possibility that RPTPbeta function in RPTPbeta -/- mice is compensated for by another tyrosine phosphatase.

Evidence from in vitro studies suggests that RPTPbeta family members play a key role in neuronal migration, neurite outgrowth, and cell adhesion. The secreted form of RPTPbeta , phosphacan, is a chondroitin sulfate, highly expressed in the brain. Phosphacan inhibits nerve growth factor-induced neurite outgrowth of PC12D in culture (22) and neurite outgrowth of dorsal root ganglia explants (14). In contrast, phosphacan promotes neurite outgrowth from mesencephalic and hippocampal neurons (8). We tested whether dorsal root ganglia prepared from day 15 embryo RPTPbeta -/- or control samples and cultured for 2 weeks showed any changes in neurite length, but we did not detect any obvious difference (data not shown). We have also shown that the cells of the dentate gyrus, where RPTPbeta is highly expressed, are able to produce normal MFs, as revealed by Timm and calbindin staining. Finally, we found no obvious difference in neurite length in mesencephalic neurons demonstrating, that in vivo, RPTPbeta is not necessary for neurite growth.

RPTPbeta isoforms are found in the developing nervous system, in patterns suggesting the involvement of these enzymes in neuronal migration and axonal guidance. RPTPbeta was implicated in the differentiation of cortical neurons (27), the migration of olfactory neurons (32), and the migration of mesencephalic DA neurons (33). In the cortex, RPTPbeta is expressed in layers II, III, and IV (41), and phosphacan has been found also in layers II, IV, and VI (20). Nissl stain- as well as calbindin- or parvalbumin-immunoreactive cells exhibited no difference with respect to number and localization in RPTPbeta -deficient mice compared to control mice. We have also demonstrated that mesencephalic DA neurons migrate to their final destination in RPTPbeta -deficient mice, suggesting that RPTPbeta does not play a major role in neuronal migration. Of course, RPTPbeta could regulate the migration of a particular subset of neurons that were not detected. However, phosphacan is expressed in most parvalbumin-positive cells (20), neurons that were well localized in RPTPbeta -deficient mice.

RPTPbeta and myelination. Previous studies suggest that RPTPbeta could be involved in the formation of the paranode. RPTPbeta , contactin, and Caspr/paranodin form a complex (35) and localize to the paranodal axolemma in myelinated fibers of the peripheral nervous system and CNS (10, 31). It has been suggested that RPTPbeta is expressed in oligodendrocyte paranodal loops and can interact with the Caspr-contactin complex at the surface of the axon. RPTPbeta may therefore participate in formation of the paranode. However, we did not detect ultrastructural abnormalities in the paranodes of RPTPbeta -/- animals.

RPTPbeta is largely expressed in glial cells. There is also growing evidence that RPTPs may play a major role in glial differentiation because most RPTPs are expressed in oligodendrocytes and regulated during the process of maturation of oligodendrocytes (36). Expression of RPTPbeta is regulated during gliogenesis (6). We could not detect any differences by light microscopy. However, analysis by electron microscopy revealed that RPTPbeta -/- sheaths are normal in appearance but display abnormalities in the thicker sheaths, suggesting a greater susceptibility to deformation and disintegration as well as more cytoplasm-containing lamellae in regions that are normally compact. The results suggest that the RPTPbeta -/- myelin may be less stable than normal myelin.

Abnormalities of this kind have been seen in mutants deficient in myelin glycolipids (9), myelin basic protein (15), or proteolipid protein (16, 39). The findings for RPTPbeta -/- mice thus could reflect abnormalities in the proportions of myelin constituents. In addition, we cannot rule out the possibility that the RPTPbeta -/- oligodendrocytes are defective and that the myelin abnormalities seen are secondary to the oligodendrocyte defects.

The results presented here provide evidence regarding the role of RPTPbeta in the adult mouse. The fact that the loss of the three isoforms of RPTPbeta does not grossly affect any of the processes tested raises questions about several proposed roles of RPTPbeta in neurite outgrowth, cell migration, axon guidance, and gliogenesis. Our data suggest that RPTPbeta is not necessary for any of these events and/or that the loss of RPTPbeta may be compensated for by other PTPs expressed in the nervous system.


    ACKNOWLEDGMENTS

We thank the personnel, in particular Anna Auerbach, of the NYU Medical Center Transgenic/ES Cell Chimera facility.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Pharmacology, New York University Medical Center, 550 First Ave., New York, NY 10016. Phone: (212) 263-7111. Fax: (212) 263-7133. E-mail: Schlej01{at}popmail.med.nyu.edu.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Amaral, D. G., and P. W. Menno. 1995. Hippocampal formation, p. 443-493. In G. Paxinos (ed.), The rat nervous system. Academic Press, San Diego, Calif.
2. Barnea, G., M. Grumet, P. Milev, O. Silvennoinen, J. B. Levy, J. Sap, and J. Schlessinger. 1994. Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. J. Biol. Chem. 269:14349-14352[Abstract/Free Full Text].
3. Barnea, G., O. Silvennoinen, B. Shaanan, A. M. Honegger, P. D. Canoll, P. D'Eustachio, B. Morse, J. B. Levy, S. Laforgia, K. Huebner, et al. 1993. Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases. Mol. Cell. Biol. 13:1497-1506[Abstract/Free Full Text].
4. Brady-Kalnay, S. M., and N. K. Tonks. 1995. Protein tyrosine phosphatases as adhesion receptors. Curr. Opin. Cell Biol. 7:650-657[CrossRef][Medline].
5. Canoll, P. D., G. Barnea, J. B. Levy, J. Sap, M. Ehrlich, O. Silvennoinen, J. Schlessinger, and J. M. Musacchio. 1993. The expression of a novel receptor-type tyrosine phosphatase suggests a role in morphogenesis and plasticity of the nervous system. Brain Res. Dev. Brain Res. 75:293-298[CrossRef][Medline].
6. Canoll, P. D., S. Petanceska, J. Schlessinger, and J. M. Musacchio. 1996. Three forms of RPTP-beta are differentially expressed during gliogenesis in the developing rat brain and during glial cell differentiation in culture. J. Neurosci. Res. 44:199-215[CrossRef][Medline].
7. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline].
8. Clement, A. M., S. Nadanaka, K. Masayama, C. Mandl, K. Sugahara, and A. Faissner. 1998. The DSD-1 carbohydrate epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth. J. Biol. Chem. 273:28444-28453[Abstract/Free Full Text].
9. Coetzee, T., N. Fujita, J. Dupree, R. Shi, A. Blight, K. Suzuki, K. Suzuki, and B. Popko. 1996. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86:209-219[CrossRef][Medline].
10. Einheber, S., G. Zanazzi, W. Ching, S. Scherer, T. A. Milner, E. Peles, and J. L. Salzer. 1997. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J. Cell Biol. 139:1495-1506[Abstract/Free Full Text].
11. Faissner, A., A. Clement, A. Lochter, A. Streit, C. Mandl, and M. Schachner. 1994. Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. J. Cell Biol. 126:783-799[Abstract/Free Full Text].
12. Fawcett, J. W., and R. A. Asher. 1999. The glial scar and central nervous system repair. Brain Res. Bull. 49:377-391[CrossRef][Medline].
13. Friedlander, D. R., P. Milev, L. Karthikeyan, R. K. Margolis, R. U. Margolis, and M. Grumet. 1994. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J. Cell Biol. 125:669-680[Abstract/Free Full Text].
14. Garwood, J., O. Schnadelbach, A. Clement, K. Schutte, A. Bach, and A. Faissner. 1999. DSD-1-proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage. J. Neurosci. 19:3888-3899[Abstract/Free Full Text].
15. Gould, R. M., A. L. Byrd, and E. Barbarese. 1995. The number of Schmidt-Lanterman incisures is more than doubled in shiverer PNS myelin sheaths. J. Neurocytol. 24:85-98[CrossRef][Medline].
16. Griffiths, I., M. Klugmann, T. Anderson, D. Yool, C. Thomson, M. H. Schwab, A. Schneider, F. Zimmermann, M. McCulloch, N. Nadon, and K. A. Nave. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613[Abstract/Free Full Text].
17. Grumet, M., A. Flaccus, and R. U. Margolis. 1993. Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules. J. Cell Biol. 120:815-824[Abstract/Free Full Text].
18. Grumet, M., P. Milev, T. Sakurai, L. Karthikeyan, M. Bourdon, R. K. Margolis, and R. U. Margolis. 1994. Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. J. Biol. Chem. 269:12142-12146[Abstract/Free Full Text].
19. Haug, F.-M. S. 1973. Heavy metals in the brain. A light microscopic study in the rat with Timm's sulphide silver method: methodological considerations and cytological and regional staining patterns. Adv. Anat. Embryol. Cell Biol. 47:1-71[Medline].
20. Haunso, A., M. R. Celio, R. K. Margolis, and P. A. Menoud. 1999. Phosphacan immunoreactivity is associated with perineuronal nets around parvalbumin-expressing neurones. Brain Res. 834:219-222[CrossRef][Medline].
21. Holland, S. J., E. Peles, T. Pawson, and J. Schlessinger. 1998. Cell-contact-dependent signalling in axon growth and guidance: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase beta. Curr. Opin. Neurobiol. 8:117-127[CrossRef][Medline].
22. Katoh-Semba, R., and A. Oohira. 1993. Core proteins of soluble chondroitin sulfate proteoglycans purified from the rat brain block the cell cycle of PC12D cells. J. Cell. Physiol. 156:17-23[CrossRef][Medline].
23. Kordeli, E., S. Lambert, and V. Bennett. 1995. AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. J. Biol. Chem. 270:2352-2359[Abstract/Free Full Text].
24. Krueger, N. X., and H. Saito. 1992. A human transmembrane protein-tyrosine-phosphatase, PTP zeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases. Proc. Natl. Acad. Sci. USA 89:7417-7421[Abstract/Free Full Text].
25. Levy, J. B., P. D. Canoll, O. Silvennoinen, G. Barnea, B. Morse, A. M. Honegger, J. T. Huang, L. A. Cannizzaro, S. H. Park, T. Druck, et al. 1993. The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system. J. Biol. Chem. 268:10573-10581[Abstract/Free Full Text].
26. Li, J., J. W. Tullai, W. H. Yu, and S. R. Salton. 1998. Regulated expression during development and following sciatic nerve injury of mRNAs encoding the receptor tyrosine phosphatase HPTPzeta/RPTPbeta. Brain Res. Mol. Brain Res. 60:77-88[Medline].
27. Maeda, N., and M. Noda. 1996. 6B4 proteoglycan/phosphacan is a repulsive substratum but promotes morphological differentiation of cortical neurons. Development 122:647-658[Abstract].
28. Maeda, N., and M. Noda. 1998. Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration. J. Cell Biol. 142:203-216[Abstract/Free Full Text].
29. Mansour, S. L., K. R. Thomas, and M. R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348-352[CrossRef][Medline].
30. McKeon, R. J., M. J. Jurynec, and C. R. Buck. 1999. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 19:10778-10788[Abstract/Free Full Text].
31. Menegoz, M., P. Gaspar, M. Le Bert, T. Galvez, F. Burgaya, C. Palfrey, P. Ezan, F. Arnos, and J. A. Girault. 1997. Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 19:319-331[CrossRef][Medline].
32. Nishizuka, M., S. Ikeda, Y. Arai, N. Maeda, and M. Noda. 1996. Cell surface-associated extracellular distribution of a neural proteoglycan, 6B4 proteoglycan/phosphacan, in the olfactory epithelium, olfactory nerve, and cells migrating along the olfactory nerve in chick embryos. Neurosci. Res. 24:345-355[CrossRef][Medline].
33. Ohyama, K., H. Kawano, H. Asou, T. Fukuda, A. Oohira, K. Uyemura, and K. Kawamura. 1998. Coordinate expression of L1 and 6B4 proteoglycan/phosphacan is correlated with the migration of mesencephalic dopaminergic neurons in mice. Brain Res. Dev. Brain Res. 107:219-226[CrossRef][Medline].
34. Peles, E., M. Nativ, P. L. Campbell, T. Sakurai, R. Martinez, S. Lev, D. O. Clary, J. Schilling, G. Barnea, G. D. Plowman, et al. 1995. The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell 82:251-260[CrossRef][Medline].
35. Peles, E., M. Nativ, M. Lustig, M. Grumet, J. Schilling, R. Martinez, G. D. Plowman, and J. Schlessinger. 1997. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J. 16:978-988[CrossRef][Medline].
36. Ranjan, M., and L. D. Hudson. 1996. Regulation of tyrosine phosphorylation and protein tyrosine phosphatases during oligodendrocyte differentiation. Mol. Cell Neurosci. 7:404-418[CrossRef][Medline].
37. Rasband, M. N., E. Peles, J. S. Trimmer, S. R. Levinson, S. E. Lux, and P. Shrager. 1999. Dependence of nodal sodium channel clustering on paranodal axoglial contact in the developing CNS. J. Neurosci. 19:7516-7528[Abstract/Free Full Text].
38. Rosenbluth, J. 1966. Redundant myelin sheaths and other ultrastructural features of the toad cerebellum. J. Cell Biol. 28:73-93[Abstract/Free Full Text].
39. Rosenbluth, J., W. Stoffel, and R. Schiff. 1996. Myelin structure in proteolipid protein (PLP)-null mouse spinal cord. J. Comp. Neurol. 371:336-344[CrossRef][Medline].
40. Sakurai, T., M. Lustig, M. Nativ, J. J. Hemperly, J. Schlessinger, E. Peles, and M. Grumet. 1997. Induction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase beta. J. Cell Biol. 136:907-918[Abstract/Free Full Text].
41. Shintani, T., E. Watanabe, N. Maeda, and M. Noda. 1998. Neurons as well as astrocytes express proteoglycan-type protein tyrosine phosphatase zeta/RPTPbeta: analysis of mice in which the PTPzeta/RPTPbeta gene was replaced with the LacZ gene. Neurosci. Lett. 247:135-138[CrossRef][Medline].
42. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702[CrossRef][Medline].
43. Stoker, A., and R. Dutta. 1998. Protein tyrosine phosphatases and neural development. Bioessays 20:463-472[CrossRef][Medline].


Molecular and Cellular Biology, October 2000, p. 7706-7715, Vol. 20, No. 20
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Devaux, J., Gow, A. (2008). Tight junctions potentiate the insulative properties of small CNS myelinated axons. JCB 183: 909-921 [Abstract] [Full Text]  
  • Chow, J. P. H., Fujikawa, A., Shimizu, H., Suzuki, R., Noda, M. (2008). Metalloproteinase- and {gamma}-Secretase-mediated Cleavage of Protein-tyrosine Phosphatase Receptor Type Z. J. Biol. Chem. 283: 30879-30889 [Abstract] [Full Text]  
  • Fukazawa, N., Yokoyama, S., Eiraku, M., Kengaku, M., Maeda, N. (2008). Receptor Type Protein Tyrosine Phosphatase {zeta}-Pleiotrophin Signaling Controls Endocytic Trafficking of DNER That Regulates Neuritogenesis. Mol. Cell. Biol. 28: 4494-4506 [Abstract] [Full Text]  
  • Kudo, T., Fujii, T., Ikegami, S., Inokuchi, K., Takayama, Y., Ikehara, Y., Nishihara, S., Togayachi, A., Takahashi, S., Tachibana, K., Yuasa, S., Narimatsu, H. (2007). Mice lacking {alpha}1,3-fucosyltransferase IX demonstrate disappearance of Lewis x structure in brain and increased anxiety-like behaviors. Glycobiology 17: 1-9 [Abstract] [Full Text]  
  • Lamprianou, S., Vacaresse, N., Suzuki, Y., Meziane, H., Buxbaum, J. D., Schlessinger, J., Harroch, S. (2006). Receptor Protein Tyrosine Phosphatase {gamma} Is a Marker for Pyramidal Cells and Sensory Neurons in the Nervous System and Is Not Necessary for Normal Development.. Mol. Cell. Biol. 26: 5106-5119 [Abstract] [Full Text]  
  • Foehr, E. D., Lorente, G., Kuo, J., Ram, R., Nikolich, K., Urfer, R. (2006). Targeting of the Receptor Protein Tyrosine Phosphatase {beta} with a Monoclonal Antibody Delays Tumor Growth in a Glioblastoma Model. Cancer Res. 66: 2271-2278 [Abstract] [Full Text]  
  • Berset, T. A., Hoier, E. F., Hajnal, A. (2005). The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions. Genes Dev. 19: 1328-1340 [Abstract] [Full Text]  
  • Niisato, K., Fujikawa, A., Komai, S., Shintani, T., Watanabe, E., Sakaguchi, G., Katsuura, G., Manabe, T., Noda, M. (2005). Age-Dependent Enhancement of Hippocampal Long-Term Potentiation and Impairment of Spatial Learning through the Rho-Associated Kinase Pathway in Protein Tyrosine Phosphatase Receptor Type Z-Deficient Mice. J. Neurosci. 25: 1081-1088 [Abstract] [Full Text]  
  • Yahiro, K., Wada, A., Yamasaki, E., Nakayama, M., Nishi, Y., Hisatsune, J., Morinaga, N., Sap, J., Noda, M., Moss, J., Hirayama, T. (2004). Essential Domain of Receptor Tyrosine Phosphatase {beta} (RPTP{beta}) for Interaction with Helicobacter pylori Vacuolating Cytotoxin. J. Biol. Chem. 279: 51013-51021 [Abstract] [Full Text]  
  • Garwood, J., Heck, N., Reichardt, F., Faissner, A. (2003). Phosphacan Short Isoform, a Novel Non-proteoglycan Variant of Phosphacan/Receptor Protein Tyrosine Phosphatase-{beta}, Interacts with Neuronal Receptors and Promotes Neurite Outgrowth. J. Biol. Chem. 278: 24164-24173 [Abstract] [Full Text]  
  • Tanaka, M., Maeda, N., Noda, M., Marunouchi, T. (2003). A Chondroitin Sulfate Proteoglycan PTPzeta /RPTPbeta Regulates the Morphogenesis of Purkinje Cell Dendrites in the Developing Cerebellum. J. Neurosci. 23: 2804-2814 [Abstract] [Full Text]  
  • Stoica, G. E., Kuo, A., Powers, C., Bowden, E. T., Sale, E. B., Riegel, A. T., Wellstein, A. (2002). Midkine Binds to Anaplastic Lymphoma Kinase (ALK) and Acts as a Growth Factor for Different Cell Types. J. Biol. Chem. 277: 35990-35998 [Abstract] [Full Text]  
  • Carothers, A. M., Melstrom, K. A. Jr., Mueller, J. D., Weyant, M. J., Bertagnolli, M. M. (2001). Progressive Changes in Adherens Junction Structure during Intestinal Adenoma Formation in Apc Mutant Mice. J. Biol. Chem. 276: 39094-39102 [Abstract] [Full Text]  
  • Stepanek, L., Sun, Q. L., Wang, J., Wang, C., Bixby, J. L. (2001). CRYP-2/cPTPRO is a neurite inhibitory repulsive guidance cue for retinal neurons in vitro. JCB 154: 867-878 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harroch, S.
Right arrow Articles by Schlessinger, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harroch, S.
Right arrow Articles by Schlessinger, J.